# A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies

> **NCT01793870** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 17 (actual)

## Conditions studied

- Metabolic, Cardiovascular

## Interventions

- **DRUG:** Tab carvedilol 25 mg
- **DRUG:** Tab carvedilol 6.25 mg
- **DRUG:** Powder carvedilol up to 2.5 mg

## Key facts

- **NCT ID:** NCT01793870
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-15
- **Primary completion:** 2013-06-17
- **Final completion:** 2013-06-17
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793870, "A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01793870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*